Drug Research

Micro-Sphere has added to its contract development and manufacturing expertise with new spray drying technology and increased high containment capabilities. The Swiss contract development and manufacturing organisation (CDMO), which specialises in spray drying and capsule filling, has invested more than...

Aragen Life Sciences (formerly, GVK BIO), a leading partner offering R&D and Manufacturing solutions (CRO/CDMO) for life sciences industries worldwide, expects high teens growth in 2022, with NCE development and manufacturing business growing at circa 40% year-on-year. The company, states...

AbbVie and the University of Chicago and have extended their collaboration agreement through 2025 to support preclinical oncology research. To date, the collaboration has led to novel insights related to biomarkers and therapeutic applications for existing AbbVie programs. This has...

Biognosys, a leader in proteomics solutions for drug discovery and development, announces the launch of its next-generation blood biomarker discovery solution, which will be offered as a contract research service. The service is designed to help researchers decipher the...

Biohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc. announced a strategic commercialization arrangement for rimegepant in markets outside of the United States upon approval. Rimegepant is commercialized as Nurtec® ODT in the U.S., and is indicated for the acute...

Phillips-Medisize, a Molex company and leader in drug delivery, diagnostic and MedTech devices, announces the successful collaboration with Exact Sciences, a global leader in cancer diagnostics, to advance early cancer detection. Fueled by a relentless pursuit for smarter, earlier...

Standigm Inc., the leading workflow artificial intelligence (AI) drug discovery company, announced that the company had established a Synthetic Research Center in the headquarters of SK Chemicals Co., Ltd, a life science and green chemicals company. Standigm has dramatically improved...